Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
International Cancer Conference Journal|December 15, 2025
A favorable antitumor efficacy of sotorasib in a patient with KRAS G12C-mutated pulmonary large-cell neuroendocrine carcinomaKeisuke Nakanishi, Hirokazu Ogino, Kojin Murakami, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2021
Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular CarcinomaTakeshi Imakura, Seidai Sato, Tetsu Tomonari, et al.
Nature|June 28, 2013
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretomeShin Yoshimoto, Tze Mun Loo, Koji Atarashi, et al.
International Cancer Conference Journal|January 27, 2026
A case of thymic carcinoma harboring an FGFR3 S249C mutation with durable disease control on lenvatinibNoriko Bando, Hirokazu Ogino, Kojin Murakami, et al.
The Journal of Medical Investigation : JMI|April 23, 2025
Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibodyKaori Nii, Hirokazu Ogino, Hiroki Bando, et al.
Respiratory Medicine Case Reports|July 19, 2024
Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature reviewKenya Miyamoto, Hirokazu Ogino, Takumi Kakimoto, et al.
Thoracic Cancer|September 17, 2023
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancerYohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, et al.
Respiratory Research|September 17, 2017
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activitySeidai Sato, Shintaro Shinohara, Shinya Hayashi, et al.
Cancer Science|January 20, 2026
Cancer-Specific Antihuman Podoplanin Antibody chLpMab-2f Exerts Antitumor Effects Against Pleural MesotheliomaAito Yoshida, Shinji Abe, Toshihiro Izumi, et al.
Experimental Lung Research|July 13, 2019
The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in miceHiroyasu Okazaki, Seidai Sato, Kazuya Koyama, et al.
Pageof 7